¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell labeling technique"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
cell labelling technique
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
single pass technique
ÀÏȸÅë°ú±â¹ý, ´ÜÀÏÅë°ú±â¹ý
single-shot technique
´Ü¹ßÆ÷±â¹ý
technique
1. ±â¼ú, ¼ö±â 2. ±â¹ý
volume gradient echo technique
¿ëÀû±â¿ï±â¿¡ÄÚ±â¹ý
variable bandwidth technique
´Ùº¯Á֯ļöÆø±â¹ý
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
transfontanelle technique
¼ý±¸¸Û°æÀ¯ÃÊÀ½ÆÄ°Ë»ç
transperineal technique
»ô°æÀ¯¹ý, °æÈ¸À½¹ý
transvaginal technique
Áú°æÀ¯¹ý, °æÁú¹ý
trefoil flap technique
¼¼ÀÙÇÇÆÇ¹ý
turbidometric technique
ȥʵµÃøÁ¤±â¹ý
variable bandwidth technique
´Ùº¯Á֯ļöÆø±â¹ý
volume gradient echo technique
¿ëÀû±â¿ï±â¿¡ÄÚ±â¹ý
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸Áõ
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
Langerhans giant cell
¶û±×Çѽº°Å¼¼Æ÷
Langhans giant cell
¶û±×Çѽº°Å´ë¼¼Æ÷
Leydig cell
·¹À̵ðÈ÷ ¼¼Æ÷
Leydig cell adenoma
·¹À̵ðÈ÷¼¼Æ÷¼±Á¾
Leydig cell tumor
·¹À̵ðÈ÷¼¼Æ÷Á¾¾ç
Leydig s cell
¶óÀ̵ðÈ÷¼¼Æ÷.
MCH => mean cell hemoglobin
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò
MCHC => mean cell hemogiooln concentration
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
MCV => mean cell volume
Æò±ÕÀûÇ÷±¸¿ëÀû
Merkel cell carcinoma
¸Þ¸£Ä̼¼Æ÷ ¾Ï(Á¾)
Mikulicz cell
¹ÌÄð¸®Áî ¼¼Æ÷
Muellers cell
¹Á·¯¼¼Æ÷, ºÎä»ì¾Æ±³¼¼Æ÷
NIH T cell
NIH T¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
past pointing technique
°úÁö½Ã¹ý
percent labeled mitoses technique
¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿¹ý
plaque technique
ÇöóÅ© °Ë»ç±â¹ý
plating colony count technique
ÆòÆÇ¹è¾ç Áý¶ô°è¼ö¹ý
presaturation technique
Àü Æ÷ȹý
pulse echo technique
ÆÞ½º ¿¡ÄÚ ±â¹ý
pulse-echo technique
ÆÞ½º-¿¡ÄÚ ±â¹ý (ÐüÛö)
quantitative technique
Á¤·®±â¹ý
radiochemical technique
¹æ»çÈÇбâ¹ý
radioimmunosorbent technique
¹æ»ç¸é¿ªÈí¼ö¹ý.
range technique
¹üÀ§±â¼ú
reduced bandwidth technique
Á֯ļöÆø °¨¼Ò ±â¹ý
rocket technique
·ÎÄϱâ¹ý
roll tube technique
½ÃÇè°üȸÀü¹ý
rotation technique
ȸÀü¹ý
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½